# Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

> **NCT00727428** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 110 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FluLaval® TF

## Key facts

- **NCT ID:** NCT00727428
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-05
- **Primary completion:** 2008-08-29
- **Final completion:** 2009-02-17
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727428, "Immunogenicity and Safety of GSK Biologicals' FluLaval® TF". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00727428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*